From: Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
Mean
Median
Range (pg/mL)
sVEGFR-3
Cycle 1, Day 1 (n = 62)
71145.2
70700.0
23300 – 129200
Cycle 1, Day 28 (n = 44)
39520.5
37100.0
21500 – 64600